Rulemaking Information

**ATTENTION LICENSEES**

New rules for ALL licensees 

(Pharmacists, Interns/Preceptors, Certified Oregon Pharmacy Technicians and Pharmacy Technicians) 

become effective on 3/1/2024. 

To navigate the new Oregon Administrative Rules (OARs), review the OBOP Navigation Chart. 

Rulemaking Hearing November 26, 2024

The OBOP Rulemaking Hearing will be held virtually via Teams on 11/26/2024 and begins at 9:30AM. If you wish to provide oral testimony during the hearing, sign up using the form below or email your first and last name, email address and which rule(s) you wish to provide comment on to pharmacy.rulemaking@bop.oregon.gov by 9:00AM on 11/26/2024.

If you want to listen to the hearing, dial (503) 446-4951 Phone Conference ID: 705 344 933#

Submit written comments to pharmacy.rulemaking@bop.oregon.gov before 4:30PM on 11/26/2024. 

November 26, 2024 Rulemaking Hearing

• Div 035 - Operation of Nonprescription and Medical Device, Equipment and Gas Outlets - Registration Requirements
  
• Div 115 - Pharmacists - Services: Prescribing - Protocol Compendium 
  
• Coronavirus 19 (v. 12/2024)
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2024-2025 (v. 12/2024)
• Influenza Live Attenuated Influenza Vaccine 2024-2025 (v. 12/2024)
• Respiratory Syncytial Virus (v. 12/2024)

October 11, 2024 Temporary Rule Noticed

• OAR 855-035-0005 - Operation of Nonprescription and Medical Device, Equipment and Gas Outlets - Registration Requirements *Effective 10/11/2024 
  

August 9, 2024 Temporary Rule Noticed

• OAR 855-115-0345 Pharmacists - Services: Prescribing - Protocol Compendium *Effective 8/9/2024
  
• Coronavirus 19 (v. 08/2024) 
  
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2024-2025 (v. 08/2024)
  
• Influenza Live Attenuated Influenza Vaccine 2024-2025 (v. 08/2024)
  
• Respiratory Syncytial Virus (v. 08/2024)
  

August 2024

The board permanently adopted the following rules at the August 2024 Board Meeting:

• Div 115 - Pharmacists - Services: Prescribing - Protocol Compendium *Effective 8/9/2024
  
• Continuation of Therapy including Emergency refills of insulin and early refills of opioid use disorder medications (v. 08/2024)
  
• SARS-CoV-2 Antiviral (v. 08/2024)
  
• Div 135 - Continuing Pharmacy Education - Definitions & General Requirements *Effective 8/9/2024
  
• Div 139 - Remote Dispensing Site Pharmacy - Outlet: General Requirements *Effective 8/9/2024
  

July 23, 2024 Rulemaking Hearing

• Div 115 - Pharmacists - Services: Prescribing - Protocol Compendium
  
• Continuation of Therapy including Emergency refills of insulin and early refills of opioid use disorder medications (v. 08/2024)
• SARS-CoV-2 Antiviral (v. 08/2024)
  
• 2024 HB 4002
  
• 2024 SB 1506
  
• Coronavirus 2019 (v.08/2024) 
  
• Div 135 - Continuing Pharmacy Education - Definitions & General Requirements - Veterinary 
  
• Div 139 - Remote Dispensing Site Pharmacy - Outlet: General Requirements - Mileage 
  
• REVISED NOTICE - Div 139 - Remote Dispensing Site Pharmacy - Outlet: General Requirements - Mileage 
  

June 2024

The board permanently adopted the following rules at the June 2024 Board Meeting:

• Div 115 - Pharmacists - PIC Qualifications & Limitations *REPEAL *Effective 6/20/2024
  
• Div 115 - Pharmacists - Services: Prescribing - Formulary & Protocol Compendium *Effective 6/20/2024
  
• Formulary Devices and Supplies
  
• Continuation of Therapy including Emergency Refills of Insulin
  
• Pseudoephedrine (v. 06/2021) *REPEAL *Effective 6/20/2024 
  
• Tobacco Cessation 
  
• Travel Medications 
  
• Sexually Transmitted Infections Post-exposure Prophylaxis (STI PEP) 
  
• Short-acting Opioid Antagonists 
  
• Standard Protocol for All Vaccines: Cover Page & Assessment and Treatment Care Pathway 
  
• Standard Protocol for All Vaccines: Managing Adverse Reactions 
  
• Coronavirus 19 
  
• Haemophilus Influenzae type b  
  
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2023-2024 
  
• Japanese Encephalitis 
  
• Meningococcal containing vaccines 
  
• Pneumococcal 
  
• Polio 
  
• Respiratory Syncytial Virus 
  
• Tetanus, Diphtheria containing vaccines
  
• Yellow Fever 
  
  
  
• Div 115 - Pharmacists – Services: Prescribing Practices – Short-acting Opioid Antagonists *Effective 6/20/2024
  
• Div 120 - Interns & Preceptors – Prohibited Practices *Effective 6/20/2024
  
• Div 020 - Pharmacist Prescriptive Authority – Protocol Compendium *REPEAL *Effective 6/20/2024
  
• Div 006/041/043/045/080/115/120/135/139/141 - Standards Adopted by Reference *Effective 6/20/2024
  
• Div 115 - Pharmacists - Responsibilities: Outlet - Delegation of Final Verification *Effective 6/20/2024
  

May 22, 2024 Rulemaking Hearing

• Div 115 - Pharmacists - PIC Qualifications & Limitations *REPEAL 
  
• Div 115 - Pharmacists - Services: Prescribing - Formulary & Protocol Compendium 
  
• Formulary Devices and Supplies
  
• Continuation of Therapy (v. 06/2024)
  
• Pseudoephedrine (v. 06/2021) *REPEAL
  
• Tobacco Cessation (v. 06/2024)
  
• Travel Medications (v. 06/2024)
• Sexually Transmitted Infections Post-exposure Prophylaxis (STI PEP) (v. 06/2024)
• Short-acting Opioid Antagonists (v. 06/2024)
• Standard Protocol for All Vaccines: Cover Page & Assessment and Treatment Care Pathway (v. 06/2024)
• Standard Protocol for All Vaccines: Managing Adverse Reactions (v. 06/2024)
• Coronavirus 19 (v. 06/2024)
• Haemophilus Influenzae type b  (v. 06/2024)
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2023-2024 (v. 06/2024)
• Japanese Encephalitis (v. 06/2024)
• Meningococcal containing vaccines (v. 06/2024)
• Pneumococcal (v. 06/2024)
• Polio (v. 06/2024)
• Respiratory Syncytial Virus (v. 06/2024)
  
• Tetanus, Diphtheria containing vaccines (v. 06/2024)
• Yellow Fever (v. 06/2024)
  
• Div 115 – Pharmacists – Services: Prescribing Practices – Short-acting Opioid Antagonists 
  
• Div 120 – Interns & Preceptors – Prohibited Practices
  
• Div 020 – Pharmacist Prescriptive Authority – Protocol Compendium *REPEAL
  
• Div 006/041/043/045/080/115/120/135/139/141 – Standards Adopted by Reference
• Div 115 - Pharmacists - Responsibilities: Outlet - Delegation of Final Verification 
  
  

March 4, 2024 Temporary Rule Noticed

• OAR 855-115-0345 Pharmacist- Services: Prescribing - Protocol Compendium - Vaccines - Coronavirus 19  *Effective 3/4/2024 
• Coronavirus 19 
  

March 2024 Temporary Rule Noticed

• OAR 855-115-0345 Pharmacist- Services: Prescribing - Protocol Compendium - Vaccines *Effective 3/1/2024
  

March 2024

The board permanently repealed the following rules at the Special February 23, 2024 Board Meeting:

• OAR 855-019-0270, OAR 855-019-0280, OAR 855-019-0290 and OAR 855-025-0024 related to Pharmacist/COPT/PT Administration of Vaccines  *Effective 2/29/2024
  

The board permanently adopted the following rule at the February 2024 Board Meeting:

• OAR 855-115-0150 Pharmacist- Prohibited Practices *Effective 3/1/2024
  

February 2024 Temporary Rule Noticed 

• Division 020 related to Temporary Suspension of Pharmacist Prescriptive Authority - Protocol Compendium *Effective 2/29/2024
  

February 2024

The board permanently adopted the following rules at the February 2024 Board Meeting:

• Division 001 related to Procedural Rules - Repeal  *Effective 2/29/2024
  
• Division 006 related to Definitions  *Effective 3/1/2024
  
• Division 010 related to Board Administration & Policies - Repeal  *Effective 2/29/2024
  
• Division 019 related to Pharmacists - Repeal  *Effective 2/29/2024
  
• Division 020 related to Pharmacist Prescriptive Authority - Repeal  *Effective 2/29/2024
  
• Division 025 related to Pharmacy Technicians - Repeal  *Effective 2/29/2024
  
• Division 031 related to Interns - Repeal  *Effective 2/29/2024 
  
• Divisions 041/110 related to Consulting Drugless Pharmacies  *Effective 2/29/2024 
  
• Division 041 related to Institutional Drug Outlet Labeling Requirements for Short-acting Opioid Antagonists *Effective 2/15/2024
  
• Division 115 related to Pharmacists - Applicability  *Effective 3/1/2024
  
• Division 115 related to Pharmacists - Collaborative Drug Therapy Management (CDTM)  *Effective 3/1/2024
  
• Division 120 related to Preceptor License Renewal or Reinstatement  *Effective 3/1/2024
  

February 22, 2024 Rulemaking Hearing

• OAR 855-019-0270, OAR 855-019-0280, OAR 855-019-0290 and OAR 855-025-0024 related to Pharmacist/COPT/PT Administration of Vaccines *REPEAL
  

January 24, 2024 Rulemaking Hearing

• Division 001 related to Procedural Rules *REPEAL
  
• Division 006 related to Definitions 
  
• Division 010 related to Board Administration and Policies *REPEAL 
  
• Division 019 related to Pharmacists *REPEAL 
  
• Division 020 related to Pharmacist Prescriptive Authority *REPEAL 
  
• Division 025 related to Pharmacy Technicians *REPEAL 
  
• Division 031 related to Interns *REPEAL 
  
• Divisions 041/110 related to Consulting Drugless Pharmacies *Rule Amendments and REPEAL
  
• Division 041 related to Institutional Drug Outlet Labeling Requirements for Short-acting Opioid Antagonists
  
• Division 115 related to Pharmacists - Applicability
  
• Division 115 related to Pharmacists - Collaborative Drug Therapy Management (CDTM)
  
• Division 115 related to Pharmacists - Prohibited Practices
  
• Division 120 related to Preceptor License Renewal or Reinstatement 
  

2023 Proposed & Adopted Rules 

December 2023 Temporary Rule Noticed

• Division 041 related to Institutional Drug Outlet Labeling for Short-acting Opioid Antagonist  *Effective 1/1/2024 
  

December 2023

The board permanently adopted the following rules at the December 2023 Board Meeting:

• Divisions 019/025/041/139 related to Pharmacist/COPT/PT Administration of Vaccines *Effective 1/1/2024
  
• Division 020 related to Vaccination Protocols - Protocol Compendium *Effective 2/1/2024
  
• Standard Protocol for All Vaccines: Cover Page & Assessment and Treatment Care Pathway (v. 2/2024)
  
• Standard Protocol for All Vaccines: Managing Adverse Reactions (v. 2/2024)
  
• Cholera (v. 2/2024)
  
• Coronavirus 19 (v. 2/2024)
  
• Haemophilus Influenzae type b (v. 2/2024)
  
• Hepatitis A containing vaccines (v. 2/2024)
  
• Hepatitis B containing vaccines (v. 2/2024)
  
• Human Papillomavirus (v. 2/2024) 
  
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2023-2024 (v. 2/2024)
  
• Influenza Live Attenuated Influenza Vaccine 2023-2024 (v. 2/2024) 
• Japanese Encephalitis (v. 2/2024) 
  
• Measles, Mumps & Rubella containing vaccines (v. 2/2024) 
• Meningococcal containing vaccines (v. 2/2024) 
  
• Pneumococcal (v. 2/2024) 
  
• Polio (v. 2/2024) 
  
• Rabies (v. 2/2024)
• Respiratory Syncytial Virus (v. 2/2024)
  
• Tetanus, Diphtheria containing vaccines (v. 2/2024) 
  
• Typhoid (v. 2/2024) 
  
• Varicella containing vaccines (v. 2/2024) 
  
• Yellow Fever (v. 2/2024) 
• Zoster (v. 2/2024) 
  
• Division 041 related to Drug Outlet Pharmacy Requirements: Personnel, General, Non-Resident, Prescription, Laboratory, & Prescription Transfers *Effective 3/1/2024
  
• Division 080 related to Schedule II Prescriptions *Effective 12/19/2023
  
• Divisions 115/125 related to Pharmacist/COPT/PT Administration of Vaccines *Effective 3/1/2024
  
• Division 115 related to Pharmacist Supervision, Counseling, PIC: Qualifications & Limitations *Effective 3/1/2024
  
• Division 125 related to Pharmacy Technician Prohibited Practices *Effective 3/1/2024 
  

November 21, 2023 Rulemaking Hearing

• Divisions 019/025/041/139 related to Pharmacist/COPT/PT Administration of Vaccines
• Division 020 related to Vaccination Protocols - Protocol Compendium 
  
• Standard Protocol for All Vaccines: Cover Page & Assessment and Treatment Care Pathway (v. 10/2023)
  
• Standard Protocol for All Vaccines: Managing Adverse Reactions (v. 10/2023)
  
• Cholera (v. 10/2023)
  
• Coronavirus 19 (v. 10/2023)
  
• Haemophilus Influenzae type b (v. 10/2023)
  
• Hepatitis A containing vaccines (v. 10/2023)
  
• Hepatitis B containing vaccines (v. 10/2023)
  
• Human Papillomavirus (v. 10/2023) 
• Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2023-2024 (v. 10/2023)
  
• Influenza Live Attenuated Influenza Vaccine 2023-2024 (v. 10/2023) 
  
• Japanese Encephalitis (v. 10/2023) 
  
• Measles, Mumps & Rubella containing vaccines (v. 10/2023) 
  
• Meningococcal containing vaccines (v. 10/2023) 
  
• Pneumococcal (v. 10/2023) 
  
• Polio (v. 10/2023) 
  
• Rabies (v. 10/2023) 
  
• Respiratory Syncytial Virus (v. 10/2023)
  
• Tetanus, Diphtheria containing vaccines (v. 10/2023) 
  
• Typhoid (v. 10/2023) 
  
• Varicella containing vaccines (v. 10/2023) 
  
• Yellow Fever (v. 10/2023) 
  
• Zoster (v. 10/2023)
  
• Division 041 related to Drug Outlet Requirements 
  
• Division 080 related to Schedule II Prescriptions
• Divisions 115/125 related to Pharmacist/COPT/PT Administration of Vaccines
• Division 115 related to Pharmacist Applicability, Definitions, Supervision, Counseling, PIC:Qualifications & Limitations, and CPA & CDTM
• Division 125 related to Pharmacy Technician Prohibited Practices

October 2023

The board permanently adopted the following rules at the October 2023 Board meeting:

• Division 007 related to Compliance w/OHA COVID-19 rules - Repealed  *Effective 10/17/2023
  
• Divisions 019/041/043/044/139 related to Short-acting Opioid Antagonist  *Effective 10/17/2023 
• Division 045 related to USP <795> and USP <797> Standards adopted by Reference  *Effective 10/17/2023
• Division 115 related to Short-acting Opioid Antagonist  *Effective 3/1/2024
  
  

September 27, 2023 Rulemaking Hearing

• Division 007 related to Compliance w/OHA COVID-19 rules
  
• Divisions 019/041/043/044/139 related to Short-acting Opioid Antagonist 
  
• Division 045 related to USP <795> and USP <797> Standards Adopted by Reference 
• Division 115 related to Short-acting Opioid Antagonist
  
• Divisions 115/125 related to RPH Applicability, Definitions, Counseling; COPT/PT Prohibited Practices
  

August 2023

The board permanently adopted the following rules at the August 2023 Board meeting:

• Division 102 related to Board Administration  *Effective 3/1/2024
  
• Division 104 related to Universal Rules  *Effective 3/1/2024
• Division 115 related to Pharmacists  *Effective 3/1/2024 
• Division 120 related to Interns and Preceptors  *Effective 3/1/2024 
• Division 125 related to Pharmacy Technicians  *Effective 3/1/2024
  

July 26, 2023 Rulemaking Hearing

• Division 080 related to Schedule I - Xylazine
  
• Division 102 related to Board Administration
  
• Division 104 related to Universal Rules 
  
• Division 115 related to Pharmacists
  
• Division 120 related to Interns and Preceptors
  
• Division 125 related to Pharmacy Technicians 

• Divisions 041/043/183 related to Drug Compounding  *THE BOARD DOES NOT INTEND TO ADOPT THESE RULES IN AUGUST 2023 - SEEKING PUBLIC COMMENT ONLY

June 2023

The board permanently adopted the following rules at the June 2023 Board meeting:

• Divisions 006/041/043/045/080/139/141 related to Standards Adopted by Reference  *Effective 6/13/2023
  
• Divisions 019/020 related to Pharmacist Prescriptive Authority  *Effective 6/13/2023
  
• Continuation of Therapy including Emergency Refills of Insulin v. 6/2023
  
• Travel Medications v. 6/2023
  
• HIV Post-exposure Prophylaxis (PEP) v. 6/2023 
  
• HIV Pre-exposure Prophylaxis (PrEP) v. 6/2023 
• Contraception v. 6/2023 
• Divisions 019/041/043/045/080/139/141/143 related to Annual Self-Inspection Form Completion Date *Effective 8/1/2023 
  

May 23, 2023 Rulemaking Hearing

• Divisions 006/041/043/045/080/139/141 related to Standards Adopted by Reference
  
• Divisions 019/020 related to Pharmacist Prescriptive Authority
• COVID-19 Monoclonal Antibody & COVID-19 Antiviral Protocols *Repeal 
• Continuation of Therapy including Emergency Refills of Insulin v. 6/2023 
• Travel Medications v. 6/2023
  
• HIV Post-exposure Prophylaxis (PEP) v. 6/2023
  
• HIV Pre-exposure Prophylaxis (PrEP) v. 6/2023 
• Contraception v. 6/2023
  
• Divisions 019/041/043/045/080/139/141/143 related to Self-Inspection Form Completion Date
  

April 2023 Temporary Rule Noticed

• Division 045 related to USP <795> & USP <797> Adopted Standards by Reference  *Effective 5/5/2023

February 2023

The board permanently adopted the following rules as the February 2023 Board meeting:

• Divisions 019/041 related to Safe Pharmacy Practice Conditions: RPH Autonomy, Outlet Requirements *Effective 2/14/2023
  
• Division 110 related to Pharmacy Prescription Kiosk (PPK) Registration Fee *Effective 2/15/2023
  
• Division 019 related to Definitions *Effective 2/14/2023 
  

February 2023 Temporary Rule Noticed

• Division 020 - related to Protocols for COVID-19 Monoclonal Antibody & COVID-19 Antiviral *Effective 2/10/2023
  

January 26, 2023 Rulemaking Hearing

• Divisions 019/041 related to Safe Pharmacy Practice Conditions: RPH Autonomy, Outlet Requirements 
  
• Division 110 related to Pharmacy Prescription Kiosk (PPK) Registration Fee 
  
• Division 019 related to Definitions 
  

2023 Rulemaking Hearing Videos 

2022 Rulemaking

December 2022

The board permanently adopted the following rules at the December 2022 Board meeting: 

• Division 019 - related to 2022 HB 4034 Duties of a Pharmacist  *Effective 12/21/2022
• Division 139 - related to 2022 HB 4034 Prohibited Practices  *Effective 12/21/2022
• Division 019 - related to 2022 HB 4096 Out-of-state Volunteer Pharmacist  *Effective 12/21/2022
• Division 062 - related to Drug Distribution Agent  *Effective 12/21/2022
• Divisions 010/019/020 - related to Pharmacist Prescriptive Authority  *Effective 2/1/2023
  
• COVID-19 Antiviral (Paxlovid)  v. 12/2022  *Effective 2/1/2023
  
• Travel Medications  v. 12/2022  *Effective 2/1/2023 
• PEP  v. 12/2022  *Effective 2/1/2023
• PrEP v. 12/2022  *Effective 2/1/2023 
• Contraception v. 12/2022  *Effective 2/1/2023 
• Divisions 021/135 - related to Continuing Pharmacy Education  *Effective 7/1/2023 
• Divisions 019/141 - related to Pharmacy Prescription Kiosk (PPK)  *Effective 2/15/2023 
• Division 006 - related to Definitions  *Effective 12/21/2022 
• Division 041 - related to Prescription Labeling Expiration Date  *Effective 12/21/2022 
  

November 22, 2022 Rulemaking Hearing

• Division 019 - related to 2022 HB 4034 Duties of a Pharmacist 
• Division 139 - related to 2022 HB 4034 Prohibited Practices 
• Division 019 - related to 2022 HB 4096 Out-of-state Volunteer Pharmacist
  
• Division 062 - related to Drug Distribution Agent 
• Divisions 010/019/020 - related to Pharmacist Prescriptive Authority 
  
• COVID-19 Antiviral (Paxlovid)
  
• Travel Medications 
  
• PEP
  
• PrEP 
  
• Contraception 
  
• Divisions 021/135 - related to Continuing Pharmacy Education 
  
• Divisions 019/141 - related to Pharmacy Prescription Kiosk (PPK)
  
• Divisions 006/019/031 - related to Definitions
  
• Division 041 - related to Prescription Labeling Expiration Date
  
• Divisions 001/102 - related to Procedural & Universal Rules - *The board does not intend to adopt these rules in December 2022 - seeking public comment only 
  
• Divisions 025/125 - related to Pharmacy Technicians - *The board does not intend to adopt these rules in December 2022 - seeking public comment only 
  
• Divisions 019/020/031/041/115 - related to Pharmacists - *The board does not intend to adopt these rules in December 2022 - seeking public comment only
  

October 2022 Temporary Rules Noticed

• Division 020 - Pharmacist Prescriptive Authority - COVID-19 Antiviral  *Effective 10/17/2022
  
• COVID-19 Antiviral v.10/2022
• Division 041 - Prescription Labeling Expiration Date *Effective 10/17/2022
  

July 2022 Temporary Rules Noticed

• Division 019 - Duties of a Pharmacist - 2022 HB 4034 *Effective 7/1/2022
  
• Division 139 - RDSP Prohibited Practices - 2022 HB 4034 *Effective 7/1/2022
  

June 2022

The board permanently adopted the following rules at the June 2022 Board Meeting: 

• Divisions 006/041/043/045/080/139 - related to Standards Adopted by Reference & Definitions  *Effective 6/16/2022
  
• Divisions 019/025/041 - related to Certified Oregon Pharmacy Technician/Pharmacy Technician Final Verification *Effective 6/16/2022
  
• Divisions 019/041/139 - related to Interpreters  *Effective 9/1/2022
  
• Divisions 019/143 - related to Pharmacy Prescription Lockers *Effective 6/16/2022
  
• Division 020 - related to Pharmacist Prescriptive Authority - Tobacco Cessation & PrEP *Effective 6/16/2022
  
• Division 031 - related to Public Health Emergency Sunset *Effective 6/16/2022
  
• Division 041 - related to Telework *Effective 6/16/2022
  
• Divisions 041/139 - related to Permanent Pharmacy Closure Requirements *Effective 6/16/2022
  
• Division 080 - related to Pseudoephedrine/Ephedrine & Interns *Effective 6/16/2022
  
• Division 110 - related to Drug Outlet Categories *Effective 6/16/2022
  
• Division 139 - related to RDSP *Effective 6/16/2022
  
  

• Divisions 006/041/043/045/080/139 - related to Standards Adopted by Reference (and Definitions)
  
• Divisions 019/025/041 - related to Certified Oregon Pharmacy Technician/Pharmacy Technician Final Verification
  
• Divisions 019/041/139 - related to Interpreters 
  
• Divisions 019/143 - related to Pharmacy Prescription Lockers 
  
• Division 020 - related to Pharmacist Prescriptive Authority - Tobacco Cessation & PrEP
  
• Division 031 - related to Public Health Emergency Rules sunset 
  
• Division 041 - related to Telework 
  
• Divisions 041/139 - related to Permanent Pharmacy Closure Requirements 
  
• Division 080 - related to Pseudoephedrine/Ephedrine & Interns 
  
• Division 110 - related to Drug Outlet Categories 
  
• Division 139 - related to RDSP 
  

April 22, 2022 Temporary Rules Noticed

• Divisions 006/019/025/041 - related to Certified Oregon Pharmacy Technician/Pharmacy Technician Final Verification  *Effective 4/22/2022
  
• Division 041 - related to Telework *Effective 4/22/2022
  
• Division 080 - related to Pseudoephedrine/Ephedrine & Interns *Effective 4/22/2022
  
• Division 139 - related to RDSP *Effective 4/22/2022
  

The board permanently adopted the following rules at the April 2022 Board Meeting: 

• Divisions 006/041/139 - related to Definitions  *Effective 4/20/2022
  
• Division 020 - related to COVID-19 Antigen Self-Test Protocol *Effective 4/20/2022
  
• Divisions 020/041/065/139 related to Alarm, Audiovisual Communication, Entry & Surveillance Systems *Effective 4/20/2022
  
• Divisions 021/025/110 - related to Certified Oregon Pharmacy Technician & Pharmacy Technician Licensure *Effective 4/20/2022
  
• Division 041 - related to Disclosure of Patient Information *Effective 4/20/2022
  
• Division 041/139 - related to Accurate Pharmacy Hours & Temporary Pharmacy Closures *Effective 4/20/2022
  
• Division 080 - related to Schedule I Exceptions *Effective 4/20/2022
  
• Division 143 - related to Pharmacy Prescription Lockers (PPLs)  *Effective 4/20/2022
  

March 30, 2022 Temporary Rule Noticed

• Division 007- related to Emergency Registration Designation *Effective 3/30/2022 
  

March 29, 2022 Temporary Rule Noticed

• Division 007 - related to 91-day Extension after a Declared Emergency Ends *Effective 3/29/2022
  

March 29, 2022 Rulemaking Hearing

• Divisions 006/041/139 - related to Definitions
  
• Division 020 - related to COVID-19 Antigen Self-Test Protocol
  
• Divisions 020/041/065/139 - related to Alarm, Audiovisual Communication, Entry & Surveillance Systems
  
• Divisions 021/025/110 - related to Pharmacy Technician & Certified Oregon Pharmacy Technician Licensure
  
• Division 041- related to Disclosure of Patient Information
  
• Divisions 041/139 - related to Accurate Pharmacy Hours & Temporary Pharmacy Closures
  
• Divisions 041/139 - related to Drug Storage
  
• Division 080 - related to Schedule I Exceptions
  
• Division 143 - related to Pharmacy Prescription Lockers (PPLs) 
  

March 21, 2022

The board permanently adopted the following rules at the December 9, 2021 Board Meeting:

• Division 110 - related to Supervising Physician Dispensing Outlet fees  *Effective 3/31/2022
  

February 16, 2022 Temporary Rules Noticed

• Division 021/025/110 - related to Pharmacy Technician & Certified OR Pharmacy Technician Licensure *Effective 2/16/2022
  
• Division 041/139 - related to Permanent Closure Requirements for Pharmacies *Effective 2/16/2022
  

• Division 001/041 - related to Procedural Rules/Operations of Pharmacies
  
• Division 006/050 - related to Definitions 
• Division 007 - related to Public Health Emergency (Intern ratio) 
• Division 019/021/025/031 - related to Cultural Competency Continuing Education 
• Division 041 - related to Epinephrine 
• Division 041/043/044 - related to Limited English Proficiency (LEP) Informational insert 
  
• Division 041 - related to Drug Take Back 
  
• Division 020 - related to Pharmacist Prescriptive Authority - Protocols 
  
• Division 080 - related to Controlled Substances 
  
• Division 110 - related to Fees